Fluonic’s technology recognizes the type of drug and precisely monitors/controls drug flow and communicates this information wirelessly to avoid adverse events.
Infusion is used in > 90% of hospital treatments, with>$10B sales per year. Yet infusion systems suffer from an alarming limitation: they are unable to determine the drug flowing through them, flow they create or that flow is entering the patient. This limitation causes > 7,000 deaths and > 1.5M adverse events/year costing hospitals > $4B annually. Fluonic solves this problem and transmits this information wirelessly to health care providers.